PALO ALTO - Guardant Health, Inc. (NASDAQ:GH) announced Monday the expansion of its Guardant Reveal blood test to include therapy response monitoring for patients with advanced solid tumors. The ...

But that doesn't mean you can't use smart shortcuts. If you're considering INUV, try chatting with WarrenAI, our powerful AI financial assistant. It's just like ChatGPT for investors, but with access ...

Investing.com - Cantor Fitzgerald lowered its price target on Camden Property Trust (NYSE:CPT) to $105 from $115 on Monday, while maintaining a Neutral rating on the real estate investment trust.

CoreCivic adds $200 million to share repurchase program ...

Investing.com - Truist Securities has lowered its price target on Chemours (NYSE:CC) to $18.00 from $21.00 while maintaining a Buy rating on the chemical company’s stock. Chemours currently trades at ...

LONDON - UBS Investment Bank announced Monday it may act as stabilizing manager for Danske Mortgage Bank Plc’s upcoming short 3-year and 7-year dual-tranche covered bonds offering. The stabilization ...

Palvella Therapeutics stock price target raised to $105 by Truist ...

Investing.com - TD Cowen has reduced its price target on Charles River Laboratories (NYSE:CRL) to $197.00 from $205.00 while maintaining a Buy rating on the stock. The new target still represents ...

SAN FRANCISCO - Nextdoor Holdings, Inc. (NYSE:NXDR) announced Monday a partnership with Waze to integrate real-time traffic and road alerts into its neighborhood network platform. The social media ...

Leerink Partners lowers Eledon Pharmaceuticals stock price target to $5 from $8 ...